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Abstract
Background: Little has been known about the demographic and clinical features of the melancholic subtype of major
depressive disorder (MDD) in Chinese patients. This study examined the frequency of melancholia in Chinese MDD patients
and explored its demographic and clinical correlates and prescribing patterns of psychotropic drugs.
Methods: A consecutively collected sample of 1,178 patients with MDD were examined in 13 psychiatric hospitals or
psychiatric units of general hospitals in China nationwide. The cross-sectional data of patients’ demographic and clinical
characteristics and prescriptions of psychotropic drugs were recorded using a standardized protocol and data collection
procedure. The diagnosis of the melancholic subtype was established using the Mini International Neuropsychiatric
Interview (MINI). Medications ascertained included antidepressants, mood stabilizers, antipsychotics and benzodiazepines.
Results: Six hundred and twenty nine (53.4%) of the 1,178 patients fulfilled criteria for melancholia. In multiple logistic
regression analyses, compared to non-melancholic counterparts, melancholic MDD patients were more likely to be male
and receive benzodiazepines, had more frequent suicide ideations and attempts and seasonal depressive episodes, while
they were less likely to be employed and receive antidepressants and had less family history of psychiatric disorders and
lifetime depressive episodes.
Conclusions: The demographic and clinical features of melancholic MDD in Chinese patients were not entirely consistent
with those found in Western populations. Compared to non-melancholic MDD patients, melancholic patients presented
with different demographic and clinical features, which have implications for treatment decisions.
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Since the term melancholia was first operationally defined in the
DSM-III [1,2], melancholic depression, also described as ‘‘typi-
cal’’, ‘‘endogenous’’, ‘‘endogenomorphic’’, ‘‘type A’’ and ‘‘auton-
omous’’ depression [3–5], has been the topic of continuous debate
whether it represents an etiologically distinct syndrome or only a
more severe variant of major depression. In DSM-III melancholia
was not listed as a separate diagnosis [1]; in DSM-IV, it was still
not separated from major depressive disorder (MDD) [6]. Both the
DSM-III and DSM-IV melancholia criteria are inconsistent with
features of melancholia described by empirical studies in which it
is postulated as a distinct entity in terms of clinical profile,
treatment response and biological markers [7,8]. For example,
compared to non-melancholic depression, melancholic depression
usually respond better to electroconvulsive therapy (ECT) and
broad-action tricyclic (TCA) than other classes of antidepressants
[8]. Therefore, many researchers advocate that melancholia be
listed as a distinct, identifiable and separate mood syndrome in the
coming DSM-V classification [7].
In the past decade the characteristic features of melancholia
have been comprehensively studied with varying results [9–11].
For example, some studies found that melancholia was more
frequent in men [9,12], which was not confirmed in other studies
[11]. In addition, these findings were almost entirely obtained in
Western populations. Given the fact that features of mood
disorders are not independent of the complex interplay of the
biopsychosocial environment [13], research findings in the West
do not cover the full range of mood symptoms experienced by
Chinese patients [14,15]. Thus, it is necessary to examine the
demographic and clinical features in Chinese melancholic patients.
There have been limited data on the frequency and features of
melancholic MDD in East Asia including China. In a recent study
Sun et al. [16] interviewed 1,970 Chinese women with MDD
diagnosed by the Composite International Diagnostic Interview
(CIDI) and found that in contrast to non-melancholia, melancholic
MDD patients were older, had older age at onset, more episodes of
illness and higher rates of lifetime generalized anxiety disorder.
However, major weaknesses of this study including convenience
sampling and inclusion of only female patients limit the
generalization of the findings. In addition, the use of psychotropic
drugs in melancholic MDD was not examined; this aspect has
seldom been reported in the literature. We could not locate similar
studies from other Eastern Asian countries, such as Japan and
Korea, by searching English-language journals.
In order to improve the validity of diagnosis of bipolar disorders
(BD) and rationalize its treatment, the Chinese Society of
Psychiatry initiated a nation-wide study entitled the Diagnostic
Assessment Service for People with Bipolar Disorders in China
(DASP) that aims to test the usefulness of screening tools for BD in
patients initially diagnosed as MDD [17,18]. The current study, a
secondary analysis of the data of the DASP project, set out (1) to
determine the frequency of melancholia in Chinese patients with
MDD based on the Mini International Neuropsychiatric Interview
(MINI); and (2) to explore its demographic and clinical correlates
and prescribing patterns of antidepressants, mood stabilizers,
antipsychotics and benzodiazepines.
Methods
Ethics Statement
The study protocol was approved centrally by the Clinical
Research Ethics Committee of Beijing Anding Hospital, Capital
Medical University, China and the Clinical Research Ethics
Committees of the respective study centers. All patients provided
informed consent to participate in this study.
Study Participants and Settings
The first survey of the DASP project was conducted in 13 major
psychiatric hospitals/units located in north, south, east, west and
central parts of China representing a range of clinical settings from
September 1, 2010 through February 28, 2011. Patients were
screened and enrolled if they were aged between 16 and 65 years,
were inpatients or outpatients, had a diagnosis of DSM-IV MDD
ascertained by the MINI, understood the aims of the study and
provided informed consent. Exclusion criteria included (1) past
diagnosis of BD; (2) history or ongoing significant medical or
neurological condition(s); (3) depressive disorders secondary to a
general medical or neurological condition; and (4) Having received
electroconvulsive therapy (ECT) in the past month.
Instrument and Assessment Procedure
Consecutive sampling method was used in this study. Patients
with a diagnosis of MDD receiving treatment in the participating
hospitals/units were consecutively referred by their treating
psychiatrists to the research team to be screened for eligibility.
Patients fulfilling the above entry criteria were invited to
participate in the study.
The patients’ basic demographic and clinical data were
collected with a questionnaire designed for the study in the course
of a clinical interview supplemented by a review of their medical
records. Following an earlier study [19], the diagnostic assessment
of melancholia was conducted with the Chinese version of the
MINI, Version 5.0, to establish DSM-IV diagnosis of the
melancholic subtype of MDD [20,21].
Prior to the study all thirteen raters were trained in the use of
MINI in twenty patients with MDD. In this reliability exercise, the
kappa values of their judgments on melancholia were more than
0.80 for each rater. After providing written consent following a full
explanation about the study, participating patients met a rater for
a confirmatory diagnostic interview.
Analysis
Data were analyzed with the SPSS 13.0. Comparisons of the
demographic and clinical characteristics and prescribing patterns
of psychotropic drugs between melancholic patients and those
without it were performed by multiple logistic regression analyses
with the ‘‘Enter’’ method. The diagnosis of melancholia was
entered as the dependent variable and demographic and clinical
characteristics and prescribing patterns of psychotropic medica-
tions (see Table 1) were entered as independent variables. The
level of significance was set at 0.05 (two-tailed).
Results
Altogether, 1,757 patients were invited to participate in the
study; 270 (15.4%) refused, 309 (17.6%) fulfilled DSM-IV criteria
for BD and 1,178 (67.0%) for MDD. In the MDD group, 629
(53.4%) had melancholia based on the MINI. Table 1 shows the
basic demographic and clinical characteristics and the use of
psychotropic drugs for the whole sample and separately by
diagnoses. In multiple logistic regression analysis melancholic
patients were more likely to be male, receive benzodiazepines and
have more frequent suicide ideations and attempts and seasonal
depressive episodes, while they were less likely to be employed and
receive antidepressants, and had less family history of psychiatric
disorders and lifetime depressive episodes.
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The frequency of melancholia among MMD patients (53.4%)
found in this study was within the range of the 20% to 80%
reported in the literature [3]. Our result is similar to the findings in
MDD patients from Western countries; for example 50% in a US
community sample [22] and 44% in New Zealand outpatients
[10], but considerably lower than a recent finding in China [16].
In a convenience sample of 1,970 female Chinese MDD patients
81.3% were diagnosed as melancholia based on the CIDI [16].
The wide discrepancy between Sun et al.’s finding and ours might
be due to selection bias (convenience vs. consecutive sampling;
female sex vs. both sexes) and interviewing techniques (the CIDI
vs. MINI).
Sex difference in depression has been well reported with higher
heritability of depression in women [23,24]. However, it is unclear
whether sex differences exist in frequency of melancholic
depression. In line with some [9,12], but not all [11] studies, the
proportion of melancholia was more frequent in men than women
in this study. Melancholic depression is characterized with
cognitive slowing [6] and low level of functioning [11], which
could perhaps account for the lower employment rate compared
to non-melancholic MDD.
Melancholic patients had greater risk of suicidal ideation and
attempts and more use of benzodiazepines in this study, which
might be due to the severity of depression and more frequent
comorbidity, such as anxiety, in this patient group [9–11]. Unlike
previous findings in Western settings that melancholic patients
have a larger number of episodes and increased familial loading
[16,22], in this study melancholia was associated with less family
history of psychiatric disorders and lifetime depressive episodes.
Melancholia is usually more severe than the non-melancholic
subtype [11], therefore it is reasonable to assume that they are
more likely to receive antidepressant treatment. In this study,
surprisingly only 64.9% of melancholic patients were on antide-
pressants, lower than the figure (75.0%) in non-melancholic
patients. We cannot explain this striking finding based on the
current study design; this result needs to be replicated in future
surveys.
Melancholic patients had more seasonal episodes in this study, a
finding that has not been reported previously. We also have no
clear explanation for this pattern except assuming that seasonality
might be a manifestation of a disturbed biological rhythm and, as
such, a sign of the biological nature of melancholic depression.
The merits of this study are its large, multicentre sample and the
standardized diagnostic assessment of melancholic MDD. How-
ever, the results should be interpreted with caution due to certain
limitations. First, the cross-sectional nature of the study could not
reflect the causal relationships between demographic and clinical
variables and melancholic MDD. Second, no standardized
Table 1. Basic demographic and clinical characteristics of MDD patients with or without melancholia.
The whole sample
(n=1,178)
Nonmelancholic
(n=549)
Melancholic
(n=629) Statistics
a
O.R. 95% CI P
N% N % N%
Male 385 32.7 154 28.1 231 36.7 1.6 1.3, 2.1 ,0.001
Married/cohabitating 824 69.9 379 69.0 445 70.7 1.1 0.8, 1.5 0.5
Employed 812 68.9 406 74.0 406 64.5 0.7 0.5, 0.9 0.004
Education
Primary and junior secondary school 356 30.2 150 27.3 206 32.8 1.0 –- –-
Senior secondary school 312 26.5 137 25.0 175 27.8 1.0 0.7, 1.4 0.8
College and university 465 39.5 241 43.9 224 35.6 0.8 0.5, 1.1 0.1
Postgraduate 45 3.8 21 3.8 24 3.8 1.0 0.5, 1.9 0.9
Depressive episodes with increased appetite and
sleep and weight gain
179 15.2 90 16.4 89 14.1 0.9 0.6, 1.2 0.4
Depressive episodes with suicidal ideation and/or
attempts
665 56.5 304 55.4 361 57.4 1.3 1.004, 1.6 0.047
Depressive episodes with psychotic symptoms 158 13.4 67 12.2 91 14.5 1.3 0.9, 1.9 0.1
Seasonal depressive episodes 134 11.4 56 10.2 78 12.4 1.7 1.2, 2.6 0.008
Family history of psychiatric disorders 203 17.2 114 20.8 89 14.1 0.6 0.5, 0.9 0.004
Any use of antidepressants 820 69.9 412 75.0 408 64.9 0.6 0.5, 0.8 ,0.001
Any use of antipsychotics 226 19.2 104 18.9 122 19.4 1.1 0.8, 1.5 0.4
Any use of mood stabilizers 44 3.7 28 5.1 16 2.5 0.6 0.3, 1.1 0.1
Any use of benzodiazepines 192 16.3 77 14.0 115 18.3 1.6 1.1, 2.2 0.01
Mean SD Mean SD Mean SD
Age (years) 40.5 12.8 40.29 12.6 40.8 13.1 1.0 0.9, 1.01 0.6
Age at onset (years) 34.6 12.5 33.9 11.9 35.3 13.0 1.0 0.9, 1.03 0.2
Lifetime depressive episodes 1.9 2.6 2.2 2.9 1.6 2.2 0.9 0.87, 0.98 0.005
amultiple logistic regression analyses with the nonmelancholic cohort as the reference group.
doi:10.1371/journal.pone.0039840.t001
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symptoms. Third, some potentially important clinical and
psychosocial factors, such as history of childhood abuse, length
of depressive episodes and rating of stressful life events, were not
measured. Fourth, the sampling was not random, thus the sample
cannot adequately represent all MDD patients in China.
However, the participating centres are major tertiary institutions
located in different parts of China, hence the current sample is
broadly representative of the real life clinical practice in China.
Finally, most background information was gleaned from patients
or their medical records that is a hardly reliable source.
In conclusion, there are significant differences between non-
and melancholic MDD in a host of demographic and clinical
characteristics and antidepressant prescription patterns that have
implications for treatment decisions. In addition, although it has
been reported that melancholic MDD is a biologically more
distinct syndrome in a number of studies, its demographic and
clinical features in Chinese patients, such as less lifetime depressive
episodes, less likely to receive antidepressants and more seasonal
episodes, are neither entirely consistent with those found in
Western melancholic patients, nor have been reported previously.
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